- CORRESPONDENCE
An equitable route forward from China’s ‘zero COVID’ policy
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature Medicine 29, 514-515 (2023)
doi: https://doi.org/10.1038/d41591-023-00002-0
Zhicheng Wang and Kit Chan contributed equally.
Competing interests
The authors declare no competing interests.
References
Cai, J. et al. Nat. Med. 28, 1468–1475 (2022).
Zhang, P. South China Morning Post https://www.scmp.com/news/china/politics/article/3199021/chinas-zero-covid-policy-under-growing-strain-cases-continue-spread-across-country (2022).
National Health Commission. http://www.gov.cn/xinwen/2022–11/11/content_5726122.htm (2022).
National Health Commission. http://www.nhc.gov.cn/xcs/gzzcwj/202212/8278e7a7aee34e5bb378f0e0fc94e0f0.shtml (2022).
Dolby, T. et al. J. Epidemiol. Community Health 76, 646–652 (2022).
Peng, Q. et al. EBioMedicine 77, 103904 (2022).
Kusuma, D. et al. SSM Popul Health 13, 100751 (2021).
Jaafar, H. et al. Inquiry 58, 469580211062402 (2021).
Zhou, Y. et al. Lancet. Public Health 7, e1051–e1063 (2022).
Wang, D. et al. Lancet. Public Health 7, e670–e682 (2022).